Table 3 Results of the Colorectal Cancer Screening Key Performance Indicators per round.
1st ROUND | 2nd ROUND | 3rd ROUND | 4th ROUND | 5th ROUND | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
gFOBT | gFOBT | gFOBT | gFOBT | FIT | ||||||||||||||||||
n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |||||||||||
ORGANIZATIONAL | ||||||||||||||||||||||
Coverage by Invitation | 63,880 | (99.6) | 66,534 | (99.8) | 65,142 | (99.6) | 50,227 | (99.6) | 12,707 | (99.8) | 64,117 | (98.6) | ||||||||||
Participation | 11,011 | (17.2) | 14,818 | (22.3) | 17,742 | (27.2) | 15,143 | (30.2) | 4,618 | (36.3) | 22,988 | (35.9) | ||||||||||
Rescreening | * | 7,424 | (73.2) | 10,415 | (87.0) | 10,382 | (87.3) | 3,210 | (89.7) | 14,623 | (88.6) | |||||||||||
Time to FOBT result (%≤15days) | ** | ** | 16,652 | (84.7) | 14,360 | (89.1) | 3,938 | (97.2) | 21,581 | (97.7) | ||||||||||||
Time to Colonoscopy (%≤60days) | 252 | (75.4) | 77 | (72.0) | 127 | (70,9) | 83 | (88,3) | 96 | (36.4) | 696 | (61.7) | ||||||||||
PROCESS | ||||||||||||||||||||||
Colonoscopy | ||||||||||||||||||||||
Referral to Colonoscopy | 372 | (100.0) | 123 | (100.0) | 182 | (96.3) | 99 | (96.1) | 280 | (97.6) | 1,238 | (95.5) | ||||||||||
Compliance | 334 | (89.8) | 108 | (87.8) | 180 | (98.9) | 96 | (97.0) | 271 | (96.8) | 1,147 | (92.3) | ||||||||||
Caecal intubation | 308 | (92.2) | 100 | (92.6) | 164 | (91.1) | 93 | (96.9) | 255 | (94.1) | 1,122 | (97.8) | ||||||||||
Severe Complications | 3 | 9.0‰ | 0 | 0.0‰ | 2 | 11.1‰ | 1 | 10.5‰ | 3 | 11.1‰ | 10 | 8.7‰ | ||||||||||
1 st Scr. | 1 st Scr. | Subs. | 1 st Scr. | Subs. | 1 st Scr. | Subs. | 1 st Scr. | Subs. | 1 st Scr. | Subs. | ||||||||||||
n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
Inconclusive FOBT | 383 | (3.5) | 360 | (4.9) | 276 | (3.7) | 265 | (4.1) | 301 | (2.7) | 92 | (2.1) | 107 | (1.0) | 32 | (2.5) | 18 | (0.5) | 219 | (2.9) | 62 | (0.4) |
Positivity | 372 | (3.5) | 79 | (1.1) | 44 | (0.6) | 74 | (1.2) | 115 | (1.1) | 39 | (0.9) | 64 | (0.6) | 78 | (6.3) | 209 | (6.3) | 509 | (7.0) | 788 | (5.1) |
Positive Predictive Value | ||||||||||||||||||||||
Low Risk Adenoma | 22 | (6.6) | 5 | (7.1) | 2 | (5.3) | 4 | (5.6) | 9 | (8.3) | 2 | (5.6) | 4 | (6.7) | 7 | (9.3) | 17 | (8.7) | 65 | (14.9) | 119 | (16.8) |
High Risk Adenoma | 79 | (23.7) | 33 | (47.1) | 9 | (23.7) | 31 | (43.7) | 28 | (25.7) | 18 | (50.0) | 27 | (45.0) | 38 | (50.7) | 84 | (42.9) | 195 | (44.6) | 320 | (45.1) |
Cancer | 23 | (6.9) | 9 | (12.9) | 4 | (10.5) | 12 | (16.9) | 15 | (13.8) | 4 | (11.1) | 9 | (15.0) | 4 | (5.3) | 16 | (8.2) | 27 | (6.2) | 36 | (5.1) |
IMPACT | ||||||||||||||||||||||
Detection Rate | (‰) | (‰) | (‰) | (‰) | (‰) | (‰) | (‰) | (‰) | (‰) | (‰) | (‰) | |||||||||||
Low Risk Adenoma | 22 | (2.1) | 5 | (0.7) | 2 | (0.3) | 4 | (0.6) | 9 | (0.8) | 2 | (0.5) | 4 | (0.4) | 7 | (5.6) | 17 | (5.1) | 65 | (8.7) | 119 | (7.7) |
High Risk Adenoma | 79 | (7.4) | 33 | (4.7) | 9 | (1.3) | 31 | (5.0) | 28 | (2.6) | 18 | (4.3) | 27 | (2.5) | 38 | (30.5) | 84 | (25.3) | 195 | (26.1) | 320 | (20.6) |
Cancer | 23 | (2.2) | 9 | (1.3) | 4 | (0.6) | 12 | (1.9) | 15 | (1.4) | 4 | (1.0) | 9 | (0.8) | 4 | (3.2) | 16 | (4.8) | 27 | (3.6) | 36 | (2.3) |
(%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | ||||||||||||
Early Stage Cancers | 13 | (56.5) | 6 | (66.7) | 3 | (75.0) | 5 | (41.7) | 9 | (60.0) | 1 | (25.0) | 7 | (77.8) | 2 | (50.0) | 11 | (64.7) | 15 | (55.6) | 26 | (72.2) |
